Keywords: valeant, competes, xcel, pharma, buy, pharmaceuticals, international

Valeant competes Xcel Pharma buy

Article | 07 March 2005

Valeant Pharmaceuticals International has completed its $280.0 million acquisition of fellow US firm Xcel Pharmaceuticals, following the early termination by the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Valeant Pharmaceuticals

Go to company listing